Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure-Barriers and Opportunities for Improvement: The PREVAMIC Study.

Rocío Ruiz-Hueso,Prado Salamanca-Bautista, Maria Angustias Quesada-Simón,Sergi Yun,Alicia Conde-Martel,José Luis Morales-Rull,Roi Suárez-Gil,José Ángel García-García,Pau Llàcer,Eva María Fonseca-Aizpuru,Beatriz Amores-Arriaga, Ángel Martínez-González, Arola Armengou-Arxe,José Luis Peña-Somovilla,Manuel Lorenzo López-Reboiro,Óscar Aramburu-Bodas

Journal of clinical medicine（2023）

引用 0|浏览6

暂无评分

摘要

CA was the cause of HF in one out of five patients and should be screened in the elderly with HF and myocardial thickening, regardless of sex and LVEF. Few transthyretin-gene-sequencing studies were performed in older patients. In many patients, it was not possible to determine the amyloid subtype.

查看译文

关键词

cardiac amyloidosis,epidemiology,heart failure,prevalence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要